neuralink
Posted inNews

Elon Musk’s Neuralink Receives FDA Approval for Human Trials

Elon Musk's brain-implant company, Neuralink, has received approval from the U.S. Food and Drug Administration (FDA) to conduct its first-in-human clinical trial, according to the company's tweet on Friday. The trial will involve a small number of patients with severe paralysis who will be implanted with Neuralink's brain-computer interface (BCI) device. The device is designed to help patients control external devices using only their thoughts. This momentous achievement marks a significant milestone in the field…
Tags: , , ,
Cancer lensatpes med
Posted inArticles News

Success achieved with the first-in-class oral anti-cancer drug, Inobrodib, by CellCentric and Sygnature Discovery.

An integrated project team at Sygnature Discovery worked collaboratively to design, synthesise, and support the pre-clinical development of Inobrodib, a new, first-in-class oral anti-cancer drug being developed by CellCentric. What are Androgens? Androgens are ‘male hormones’ including testosterone and dihydrotestosterone. They carry out their actions through a receptor called Androgen Receptor (AR), which is expressed on many cell types and therefore plays crucial roles in the development and function of many systems in the body…
Tags: , , ,
FDA Approves First-ever Drug That Can Delay Onset of Type 1 Diabetes
Posted inNews

FDA Approves First-ever Drug That Can Delay Onset of Type 1 Diabetes

Introduction Tzield (teplizumab-mzwv) has been approved by the US Food and Drug Administration to delay the onset of type 1 diabetes in people aged 8 years and older who are at high risk for developing the condition. What is type 1 diabetes? Type 1 diabetes is a disease that develops when the immune system attacks and destroys the cells that make insulin. People who have been diagnosed with type 1 diabetes must monitor their blood…
HIV research cure
Posted inNews

WOMAN CURED OF HIV

According to a presentation at the Conference on Retroviruses and Opportunistic Infections (CROI) on Tuesday 15th February, a woman with HIV who got a cord blood stem cell transplant to treat acute myeloid leukemia has had no detectable HIV levels for 14 months despite stopping antiretroviral medication (ART). This is the third documented case of HIV remission following a stem cell transplant. The study which was led by Yvonne Bryson, M.D., of the University of…
Tags: , , , ,
LESSONS OF 2021 NOBEL PRIZE
Posted inArticles News

LESSONS OF 2021 NOBEL PRIZE

Bring 2021 Nobel Prizes into the classroom! From receptors for temperature and contact to organocatalysis. A compassionate voice of the consequences of colonialism to efforts to protect freedom of expression. Understanding complex frameworks to new bits of knowledge about the work market. Now you can show your students the accomplishments granted the current year's Nobel Prizes in a straightforward manner. Choose a lesson that covers all of the rewards for 2021 or a session that…